openPR Logo
Press release

Stromal Vascular Fraction Market to Record an Impressive Growth Rate of US$ 102 Mn by 2025

04-25-2018 03:27 PM CET | Health & Medicine

Press release from: Persistence Market Research

Stromal Vascular Fraction Market to Record an Impressive Growth

Prevalence of knee osteoarthritis is expected to provide a significant opportunity to the new class cell therapies to penetrate the market. Moreover, soaring demand for reconstructive breast therapies are also estimated to fuel the market in near future. Among all the clinical trials being conducted for stromal vascular fraction therapeutics, breast reconstruction procedures have reported highest proportion and outcomes for it to appear promising, as per the research conducted by Persistence Market Research. Another opportunity lies in the therapy for scleroderma, as there has already been an approved cell therapy that holds tremendous growth potential.

Persistence Market Research has recently published a research report on the global stromal vascular fraction, titled “Stromal Vascular Fraction Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025.” The report indicates moderate growth for the SVF market during the forecast period 2017-2025, at an estimated CAGR of 4.2%. From the global sales achieved in 2017, i.e. US$ 73.14 Mn, the market is anticipated to attain a value worth US$ 101.92 Mn by the end of 2025.

Report overview @ https://www.persistencemarketresearch.com/market-research/stromal-vascular-fraction-market.asp

Global Stromal Vascular Fraction Market: Dynamics : The growth of the global stromal vascular fraction market is primarily driven by increasing adoption in applications such as skin treatment, migraine and headaches, arthritis, diabetes, migraine, joint replacement and also in neurological conditions such as amyotrophic lateral sclerosis (ALS), neuropathy, and Parkinson’s disease. In addition, increasing prevalence and incidence of above-mentioned application are also gardening the market growth of stromal vascular fraction market. For instance, according to the research conducted, ALS affects more than 32,000 individuals and approximately 5,100 new cases diagnosed each year in U.S. alone. However, factors such as high cost of treatment and complex regulatory framework are the major obstacles in hampering the market growth of stromal vascular fraction.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/20914

Global Stromal Vascular Fraction Market: Regional Analysis : North America’s SVF market is expected to contribute more than 38% revenue share in the global market for stromal vascular fraction over 2017-2025. Increasing number of IRB approvals for new SVF deployment procedures developed by various research facilities and hospitals in the US is driving the demand for procedure the North American market. As per the report published by Persistence Market Research, North America will stay dominant throughout the forecast period, in terms of value. Asia Pacific, slated for a relatively higher CAGR value over 2017-2025, will be reportedly followed by the European market for SVF therapies. South Korea has been identified to be the fastest emerging, most lucrative regional market for stromal vascular fraction, with over 5% CAGR during the assessment period.

Request Report Multiple Chapter @ https://www.persistencemarketresearch.com/multiple-chapter/20914

Global Stromal Vascular Fraction Market: Key Players : The report includes in-depth profiles of some of the key players that are financialy active in the competitive landscape of the global stromal vascular fraction market. Cytori Therapeutics Inc., IntelliCell BioSciences Inc. , Cellular Biomedicine Group, Inc., GE Healthcare (Biosafe Group SA), Lifecell Corporation (Allergen PLC), Tissue Genesis Inc., and InGeneron, Inc. are a few of the leading players in the global marketplace for stromal vascular fraction.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stromal Vascular Fraction Market to Record an Impressive Growth Rate of US$ 102 Mn by 2025 here

News-ID: 1030524 • Views:

More Releases from Persistence Market Research

Pedestrian Entrance Control Systems Market Projected to Reach USD 3.3 Billion by 2032
Pedestrian Entrance Control Systems Market Projected to Reach USD 3.3 Billion by …
Overview of the Market The Pedestrian Entrance Control Systems (PECS) market is poised for substantial growth over the coming years, driven by the increasing demand for secure and efficient access management solutions in commercial, residential, and industrial sectors. These systems are critical for controlling pedestrian flow while ensuring safety and compliance with security protocols. The market is witnessing rapid adoption due to rising urbanization, advancements in biometric and smart access technologies,
Digital Signature Market Anticipated to Hit USD 38.5 Billion by 2032
Digital Signature Market Anticipated to Hit USD 38.5 Billion by 2032
Overview of the Digital Signature Market The global digital signature market is poised for remarkable growth, estimated to increase from US$ 8.4 billion in 2025 to US$ 38.5 billion by 2032, reflecting a robust CAGR of 25.8% during the forecast period. This surge is driven by the escalating demand for secure and efficient digital transaction solutions across industries such as BFSI, healthcare, government, and IT. Organizations are increasingly embracing digital signatures
Family/Indoor Entertainment Centers Market Estimated to Grow at 11.9% CAGR by 2032
Family/Indoor Entertainment Centers Market Estimated to Grow at 11.9% CAGR by 20 …
Overview of the Market The global family/indoor entertainment centers market is experiencing remarkable growth, fueled by increasing consumer demand for recreational and leisure activities. Estimated at US$ 46.8 billion in 2025, the market is projected to nearly double, reaching US$ 102.8 billion by 2032, registering a robust CAGR of 11.9% during the forecast period. Families and young adults are increasingly seeking immersive and interactive entertainment experiences, driving the popularity of indoor
5G Network Equipment Market Anticipated to Hit USD 101,824.3 Million by 2032: Persistence Market Research
5G Network Equipment Market Anticipated to Hit USD 101,824.3 Million by 2032: Pe …
Overview of the Market The global 5G network equipment market is set to experience exponential growth, with its size projected to rise from US$ 26,370.5 million in 2025 to US$ 101,824.3 million by 2032, reflecting a robust CAGR of 21.3% during the forecast period. The increasing need for ultra-fast wireless communication, low latency, and high network efficiency is driving the demand for 5G network infrastructure worldwide. Mobile operators and enterprises are

All 5 Releases


More Releases for Stromal

Gastrointestinal Stromal Tumor Market Trends, Epidemiology, and Market Outlook
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract, arising from interstitial cells of Cajal due to mutations in KIT or PDGFRA genes. Although GISTs are rare compared to other cancers, their treatment landscape has advanced significantly in the last two decades with the development of tyrosine kinase inhibitors (TKIs) such as imatinib, sunitinib, regorafenib, avapritinib, and ripretinib. Download Full PDF Sample Copy of Market Report
Gastrointestinal Stromal Tumor Market, Innovations in Treatment and Diagnosis Dr …
The gastrointestinal stromal tumor (GIST) market is a dynamic and growing segment of the oncology field, primarily driven by advancements in diagnostic techniques and therapies. GISTs are a type of cancer found in the digestive system, particularly the stomach and small intestine, originating from specialized cells known as interstitial cells of Cajal. These tumors are rare but critical, often detected late, making early diagnosis crucial for better outcomes. The market
Gastrointestinal Stromal Tumor Pipeline Therapeutics Assessment Report 2024 (Upd …
DelveInsight's, "Gastrointestinal Stromal Tumors Pipeline Insight 2024" report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointestinal Stromal Tumors (GIST) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options
Stromal Vascular Fraction Market is Expanding Rapidly with Promising Growth Pros …
Stromal Vascular Fraction Market latest research report added by USD Analytics. The Stromal Vascular Fraction Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in
The Stromal Vascular Fraction Market Is On an Innovative Errand
The Stromal Vascular Fraction Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire healthcare vertical
Healthcare Infographics to Increase the Visibility of Stromal Vascular Fraction …
The Stromal Vascular Fraction Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like "Online Bachelor's Degree in General Studies with a Concentration in Healthcare" is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs to